Reduced
Perceived harshness
Inhalation feels noticeably smoother in early sensory panels — the #1 complaint, softened.
The technology
We change what the consumer feels — not what the product is.
TNT is a patent-pending sensory technology platform. TIM — Taste Intensity Modulation — is the proprietary engine that shapes how taste, aroma, and harshness are perceived, without altering the underlying formulation.
Patent-pending · Prototype-validated · Licensable across categories
For food and beverage applications: TNT is designed to work within existing GRAS and food-safe ingredient frameworks. Final regulatory pathway (GRAS self-affirmation, FDA notification, or category-specific equivalent) is confirmed jointly with each licensing partner before commercial launch.
The platform
One Platform. 38 Applications.
TNT's proprietary TIM (Taste Intensity Modulation) platform can be deployed across cannabis, food, beverages, alcohol, wellness, supplements, medical applications, and more. Select a category to explore the product family.
Category
Cannabis
Available
TNT TerpSmooth
Reduces harshness while preserving terpene flavor.
Platform flow
From one technology to global licensing.
01
TNT Platform
Parent sensory IP
02
TIM Technology
Taste Intensity Modulation engine
03
38 Applications
And growing
04
Multiple Industries
Cannabis · Food · Alcohol · Wellness
05
Licensing Opportunities
Category-exclusive partnerships
Market opportunity
Industries TNT can transform.
One licensable platform. Six trillion-dollar industries within reach.
Cannabis
$32B+ U.S. MARKET
Food & Beverage
$10T+ GLOBAL MARKET
Alcohol
$1.6T+ GLOBAL MARKET
Healthcare
$11T+ GLOBAL MARKET
Dietary Supplements
$200B+ GLOBAL MARKET
Prototype results
What TIM actually delivers.
Indicative outcomes from the first commercial application, TerpSmooth. Full methodology and quantitative panel data shared with qualified partners under NDA.
First commercial application · TerpSmooth
Reduced
Throat irritation
Less scratch, less sting — consumers report a cleaner finish without losing character.
Reduced
Cough-trigger sensations
Fewer involuntary cough responses across repeated sessions in prototype evaluations.
Maintained
Flavor clarity
Terpene and aroma profile preserved — modulation without flattening the experience.
Achieved
Prototype objectives
All core sensory targets met or exceeded in the first commercial application, TerpSmooth.
Directional results from early prototype panels. Not a medical or health claim.
Next step